Search

everythinglearnresearchcommunity

for

Search:↓

Three drugs change mice's alcohol drinking patterns by affecting GABAA receptors.

Light and temperature affect the daily skin function rhythms in hairless rats, with temperature influencing water loss but not skin hydration.

New technologies in acupuncture and biosensors show promise for better medical treatments and healing.

Enhancing melanin's energy generation may help treat alopecia areata.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Bioassays help find useful compounds in nature for making medicines, supplements, and cosmetics.

The new skin cream with FOL-005 safely promotes hair growth and is stable and user-friendly.

Hair follicle testing is more reliable and effective for drug screening than urinalysis.

The document concludes that finasteride can reduce nandrolone detection in doping tests, suggesting frequent testing and setting metabolite level thresholds for detection.

Both a lock of hair and a single hair strand can show chronic drug use, but at least six single hairs are needed for accurate results.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

The tattoo machine method safely delivers an average of 1,175 µg/cm² of medication into the skin.

Finding new uses for existing drugs is promising and can lead to safer, more effective medicines.

Minoxidil response testing helps treat hair loss effectively and safely.

Liposomes improve the delivery and effectiveness of cosmetic ingredients but face challenges like cost and stability.

The peer review highlighted the need for clearer data handling, questioned the study's validity, and recognized improvements from the original version.

Reviewers suggested the study on finding new drug uses through social media side-effects needs better methods and clearer limitations.

The study improved and was accepted despite initial concerns about data clarity, methodology, and potential overfitting.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

A woman experienced severe side effects from a drug due to a specific genetic variation, suggesting genetic testing could prevent such risks.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

A hair test can accurately predict if a person with hair loss will respond to minoxidil treatment.

Hair protein analysis could improve medical testing and understanding of hair characteristics.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Minoxidil can be effectively encapsulated in coated nanovesicles for potential drug delivery.

A drug improved schizophrenia-like symptoms in stressed rats by changing brain steroid levels.